BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34295456)

  • 1. Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin Lymphoma.
    Drees EEE; Roemer MGM; Groenewegen NJ; Perez-Boza J; van Eijndhoven MAJ; Prins LI; Verkuijlen SAWM; Tran XM; Driessen J; Zwezerijnen GJC; Stathi P; Mol K; Karregat JJJP; Kalantidou A; Vallés-Martí A; Molenaar TJ; Aparicio-Puerta E; van Dijk E; Ylstra B; Groothuis-Oudshoorn CGM; Hackenberg M; de Jong D; Zijlstra JM; Pegtel DM
    J Extracell Vesicles; 2021 Jul; 10(9):e12121. PubMed ID: 34295456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients.
    van Eijndhoven MA; Zijlstra JM; Groenewegen NJ; Drees EE; van Niele S; Baglio SR; Koppers-Lalic D; van der Voorn H; Libregts SF; Wauben MH; de Menezes RX; van Weering JR; Nieuwland R; Visser L; van den Berg A; de Jong D; Pegtel DM
    JCI Insight; 2016 Nov; 1(19):e89631. PubMed ID: 27882350
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables.
    Paydas S; Acikalin A; Ergin M; Celik H; Yavuz B; Tanriverdi K
    Med Oncol; 2016 Apr; 33(4):34. PubMed ID: 26951445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characterization of extracellular vesicles-derived microRNAs in Thai malaria patients.
    Ketprasit N; Cheng IS; Deutsch F; Tran N; Imwong M; Combes V; Palasuwan D
    Malar J; 2020 Aug; 19(1):285. PubMed ID: 32778117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer.
    Ahmed SH; Espinoza-Sánchez NA; El-Damen A; Fahim SA; Badawy MA; Greve B; El-Shinawi M; Götte M; Ibrahim SA
    PLoS One; 2021; 16(4):e0250642. PubMed ID: 33901254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
    Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
    Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a.
    Barone I; Gelsomino L; Accattatis FM; Giordano F; Gyorffy B; Panza S; Giuliano M; Veneziani BM; Arpino G; De Angelis C; De Placido P; Bonofiglio D; Andò S; Giordano C; Catalano S
    J Transl Med; 2023 Mar; 21(1):232. PubMed ID: 37004031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
    Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A
    Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma.
    Jones K; Nourse JP; Keane C; Bhatnagar A; Gandhi MK
    Clin Cancer Res; 2014 Jan; 20(1):253-64. PubMed ID: 24222179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-circulating EV-miRNAs, serum TARC, and quantitative FDG-PET features in classical Hodgkin lymphoma.
    Drees EEE; Driessen J; Zwezerijnen GJC; Verkuijlen SAWM; Eertink JJ; van Eijndhoven MAJ; Groenewegen NJ; Vallés-Martí A; de Jong D; Boellaard R; de Vet HCW; Pegtel DM; Zijlstra JM
    EJHaem; 2022 Aug; 3(3):908-912. PubMed ID: 36051072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma.
    Calabretta E; di Trani M; Corrado F; Sollini M; Cristaldi V; Marino F; Terzi di Bergamo L; Bruscaggin A; Pirosa MC; Bramanti S; Chiti A; Rossi D; Carlo-Stella C
    Br J Haematol; 2024 Feb; 204(2):514-524. PubMed ID: 37853658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicle-packaged miRNA release after short-term exposure to particulate matter is associated with increased coagulation.
    Pergoli L; Cantone L; Favero C; Angelici L; Iodice S; Pinatel E; Hoxha M; Dioni L; Letizia M; Albetti B; Tarantini L; Rota F; Bertazzi PA; Tirelli AS; Dolo V; Cattaneo A; Vigna L; Battaglia C; Carugno M; Bonzini M; Pesatori AC; Bollati V
    Part Fibre Toxicol; 2017 Aug; 14(1):32. PubMed ID: 28899404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of pre-treatment FDG PET/CT-derived machine learning models for outcome prediction in classical Hodgkin lymphoma.
    Frood R; Clark M; Burton C; Tsoumpas C; Frangi AF; Gleeson F; Patel C; Scarsbrook A
    Eur Radiol; 2022 Oct; 32(10):7237-7247. PubMed ID: 36006428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small RNA sequencing of extracellular vesicles identifies circulating miRNAs related to inflammation and oxidative stress in HIV patients.
    Chettimada S; Lorenz DR; Misra V; Wolinsky SM; Gabuzda D
    BMC Immunol; 2020 Nov; 21(1):57. PubMed ID: 33176710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD.
    O'Farrell HE; Bowman RV; Fong KM; Yang IA
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors.
    Strømme O; Heck KA; Brede G; Lindholm HT; Otterlei M; Arum CJ
    Curr Issues Mol Biol; 2021 Jun; 43(1):286-300. PubMed ID: 34199766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining plasma extracellular vesicle Let-7b-5p, miR-184 and circulating miR-22-3p levels for NSCLC diagnosis and drug resistance prediction.
    Vadla GP; Daghat B; Patterson N; Ahmad V; Perez G; Garcia A; Manjunath Y; Kaifi JT; Li G; Chabu CY
    Sci Rep; 2022 Apr; 12(1):6693. PubMed ID: 35461372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature.
    Tzaridis T; Reiners KS; Weller J; Bachurski D; Schäfer N; Schaub C; Hallek M; Scheffler B; Glas M; Herrlinger U; Wild S; Coch C; Hartmann G
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.